{"id":20357,"date":"2025-09-16T18:21:08","date_gmt":"2025-09-16T18:21:08","guid":{"rendered":"https:\/\/www.newsbeep.com\/il\/20357\/"},"modified":"2025-09-16T18:21:08","modified_gmt":"2025-09-16T18:21:08","slug":"plymouth-based-celcuity-gets-closer-to-having-its-advanced-breast-cancer-drug-approved","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/il\/20357\/","title":{"rendered":"Plymouth based Celcuity gets closer to having its advanced breast cancer drug approved."},"content":{"rendered":"<p class=\"rt-Text\">The subset of breast cancer patients that Celcuity would initially target is potentially worth $4 billion to $5 billion, according to Sullivan, and approvals for additional indications would increase that market potential further.<\/p>\n<p class=\"rt-Text\">Sullivan hopes to get FDA approval for the first use of the drug in patients by the middle of 2026. <\/p>\n<p class=\"rt-Text\">Doctors and analysts who\u2019ve followed the clinical trial process are enthused. \u201cWe believe geda[tolisib] to be a blockbuster,\u201d wrote Chase Knickerbocker, an analyst with Craig-Hallum Capital Markets, in a recent note to investors.<\/p>\n<p class=\"rt-Text\">Dr. Sara Hurvitz, head of the Division of Hematology and Oncology at the University of Washington\u2019s Department of Medicine and co-principal investigator for the trial said in Celcuity\u2019s press release that results of the Phase III trial \u201care potentially practice-changing.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"The subset of breast cancer patients that Celcuity would initially target is potentially worth $4 billion to $5&hellip;\n","protected":false},"author":2,"featured_media":20358,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[163,521,85,46],"class_list":["post-20357","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-health","tag-healthcare","tag-il","tag-israel"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/20357","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/comments?post=20357"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/posts\/20357\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media\/20358"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/media?parent=20357"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/categories?post=20357"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/il\/wp-json\/wp\/v2\/tags?post=20357"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}